February 2024

UROLOGY

HIGHLIGHTS FROM THE 2024 GU ASCO SYMPOSIUM

At the 2024 ASCO Genitourinary Cancers Symposium, three distinguished faculty members from Northwestern Medicine shared valuable insights and helped advance the fields of urology and urologic oncology.
View highlights from Northwestern Medicine faculty members at the 2024 GU ASCO Symposium below.

Olaparib and Abiraterone Synergistic in Metastatic Castration-Resistant Prostate Cancer, featuring Maha H.A. Hussain, MBChB
  • Read about the latest advances in the treatment of metastatic castration-resistant prostate cancer from Dr. Hussain.

The Shortage of Drugs for Urothelial Carcinoma: Why We Can’t Get What Our Patients Need and What We Can Do About This, featuring Joshua J. Meeks, MD, PhD
  • Watch Dr. Meeks present “Bacillus Calmette-Guerin Shortage: What’s on the Horizon to Replace?”

Utilization of Neoadjuvant Chemo Before Cystectomy, featuring Hiten D. Patel, MD, MPH
  • Listen to Dr. Patel discuss findings from his team’s research on the use of neoadjuvant chemotherapy prior to radical cystectomy in patients with muscle-invasive bladder cancer.

Expert Discusses Strategies for Managing BCG Shortage in Bladder Cancer, featuring Joshua J. Meeks, MD, PhD
  • Hear Dr. Meeks discuss his plenary presentation on the current shortage of Bacillus Calmette-Guerin (BCG) and offer suggestions for oncologists on how to treat patients during this scarcity.

Refer a Patient

Northwestern Medicine welcomes the opportunity to partner with you in caring for your patients. ​

You May Also Like